home > news > detailed info

CRO and Sponsor Quality Award Finalists Announced by ACRP, The Avoca Group

The Avoca Group

Washington, DC – The Association of Clinical Research Professionals (ACRP) and The Avoca Group will jointly recognize leading Sponsors and CROs at the ACRP Awards & Recognition Ceremony on Friday, May 1, during the ACRP 2020 annual conference in Seattle, Washington.

Investigational sites chose finalists for the ACRP-Avoca Quality Awards through a research study conducted by The Avoca Group.

In this research, investigational sites rated Sponsor and CRO attributes (including responsiveness to questions, knowledge of the study protocol, and frequency of CRA turnover, among others) and study execution (including setting of realistic patient recruitment goals, design of CRF, and ease of EDC systems, etc.).

Finalists for the ACRP-Avoca CRO Quality Award include:

• Covance Inc.
• ICON plc
• PRA Health Sciences

Finalists for the ACRP-Avoca Sponsor Quality Award include:

• AstraZeneca plc
• GlaxoSmithKline plc
• Novo Nordisk A/S

Winners will be announced Friday, May 1, during the ACRP Awards & Recognition Ceremony.

“We are honored to continue our collaboration with The Avoca Group and to give clinical research sites a platform to recognize Sponsors and CROs who provide high-quality support to streamline clinical trial operations at the site level,” says Jim Kremidas, ACRP Executive Director. “Recognition of quality partners in the clinical trial community greatly supports our mission to promote excellence in clinical research.”

“Research site staff are on the front lines of clinical research, and this puts them in a unique position to nominate recipients of this award,” says Patricia Leuchten, Founder and CEO, The Avoca Group. “It’s been a pleasure to engage with sites as part of our research and to partner with ACRP to offer this award to deserving clinical trial Sponsors and CROs.”

ACRP and The Avoca Quality Consortium will also on Friday, May 1, host the ACRP-Avoca Quality Congress—bringing together executives and other key leaders to discuss patient centricity in clinical trials.

Under the theme of “Adding Electricity to Patient Centricity: Energizing Solutions,” this full-day interactive symposium will bring together executives and other key leaders from sites, sponsors, CROs and tech providers for an examination of recent trends for the use of patient-centric tools and technology, and the associated successes, challenges, and barriers for integrating adoption across all stakeholders.

Casey Orvin, President of Society for Clinical Research Sites (SCRS), will deliver the Quality Congress keynote address, “Survey Says: Clinical Trials in the Digital Age Impact All Stakeholders More than Originally Imagined.”

Orvin’s address will highlight data from several recent SCRS surveys that shine a light on industry trends, technologies to keep an eye on, the status of site education and implementation, and the concerns or and advantages to sites globally.

To learn more about the ACRP-Avoca Quality Congress, please visit:

About ACRP
In clinical research, people are everything. ACRP raises clinical research standards and accelerates careers. Better people. Better results.

About The Avoca Group
The Avoca Group leads the industry in GCP quality and compliance solutions. With 20 years of experience providing research and consulting services, Avoca merges deep institutional knowledge in the foundations of good clinical practice with future-forward leadership in regulatory compliance, quality management, and clinical operations across the evolving clinical trials landscape. The Avoca Quality Consortium, Avoca’s cross-functional collaborative, unites sponsors, CROs, and clinical service providers to address challenges and maximize opportunities to mitigate risk and improve both quality and execution in clinical trials.
phone (609) 252-9020
email 179 Nassau St., Suite 3A, Princeton, NJ 08542
Print this page
Send to a friend
News and Press Releases

Restructure Announcement at Illingworth

As a rapidly growing company, Illingworth Research Group (Illingworth) has reflected on its goals, accomplishments and ambitious future growth plans. This has allowed us to consider opportunities for staff to explore their own growth and development possibilities within a rapidly changing landscape. With that in mind, Illingworth are announcing some significant and exciting changes to our organization. Illingworth remain committed to making patient involvement in clinical trials as stress free as possible and our strengthened management team and launch of our patient concierge service, PatientGO, in combination with global, mobile research nursing will ensure as many patients as possible have the chance to participate in the development of critical drugs, regardless of their geography or socioeconomic class.
More info >>

White Papers

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific.

Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement